Zobrazeno 1 - 10
of 655
pro vyhledávání: '"C, Darke"'
Autor:
Allan Gordon, Saifudin Rashiq, Dwight E Moulin, Alexander J Clark, André D Beaulieu, John Eisenhoffer, Paula S Piraino, Patricia Quigley, Zoltan Harsanyi, Andrew C Darke
Publikováno v:
Pain Research and Management, Vol 15, Iss 3, Pp 169-178 (2010)
OBJECTIVE: The present randomized, double-blinded, crossover study compared the efficacy and safety of a seven-day buprenorphine transdermal system (BTDS) and placebo in patients with low back pain of moderate or greater severity for at least six wee
Externí odkaz:
https://doaj.org/article/c00209049ee440d48f64a49bf97d0ec8
Autor:
André D Beaulieu, Paul M Peloso, Boulos Haraoui, William Bensen, Glen Thomson, John Wade, Patricia Quigley, John Eisenhoffer, Zoltan Harsanyi, Andrew C Darke
Publikováno v:
Pain Research and Management, Vol 13, Iss 2, Pp 103-110 (2008)
OBJECTIVE: The present study was a randomized, parallel, double-blind comparison between controlled-release (CR) tramadol and sustained-release (SR) diclofenac in patients with chronic pain due to osteoarthritis of the hips and/or knees.
Externí odkaz:
https://doaj.org/article/de0f352f721d47bb89361bb06df21988
Autor:
Carter Thorne, André D Beaulieu, Denis J Callaghan, William F O’Mahony, John M Bartlett, Richard Knight, Gunnar R Kraag, Ronald Akhras, Paula S Piraino, John Eisenhoffer, Zoltan Harsanyi, Andrew C Darke
Publikováno v:
Pain Research and Management, Vol 13, Iss 2, Pp 93-102 (2008)
OBJECTIVE: To compare the efficacy and safety of controlled-release (CR) tramadol (Zytram XL, Purdue Pharma, Canada) and placebo in patients with painful osteoarthritis.
Externí odkaz:
https://doaj.org/article/d22a843631d5440fba8cc5a471625dc8
Autor:
Andrew C Darke, John H Stewart
Publikováno v:
Pain Research and Management, Vol 4, Iss 2, Pp 104-109 (1999)
While the role of opioid analgesics has been established in the treatment of cancer pain, reservations persist about appropriate use in patients with chronic noncancer pain. Recent evidence from controlled clinical trials supports the effectiveness o
Externí odkaz:
https://doaj.org/article/d48205d44b484f63bb7742473a084eb1
Autor:
Martin E Hale, Kevin L Speight, Zoltan Harsanyi, Tad Iwan, N Susan Slagle, Peter G Lacouture, Andrew C Darke
Publikováno v:
Pain Research and Management, Vol 2, Iss 1, Pp 33-38 (1997)
OBJECTIVE: To compare pain relief and stability of pain control in patients with chronic low back pain treated with scheduled 12 hourly doses of controlled-release codeine or as required doses of a fixed combination of acetaminophen and codeine.
Externí odkaz:
https://doaj.org/article/7cc83e2d79064cf1a710eb5a1265336c
Autor:
A. L. Burmistrova, C. Darke, M. N. Vavilov, S. V. Belyaeva, O N Zaripova, D. S. Stashkevich, M. S. Chernova, E. B. Khromova, Alexander Galkin, T. A. Suslova
Publikováno v:
Suslova, T A, Burmistrova, A L, Vavilov, M N, Chernova, M S, Khromova, E B, Belyaeva, S V, Zaripova, O N, Stashkevich, D S, Galkin, A S & Darke, C 2017, ' HLA gene and haplotype frequencies in a Nagaybaks population from the Chelyabinsk Region (Russian South Urals) ', Human Immunology . https://doi.org/10.1016/j.humimm.2017.08.005
A total of 112 Nagaybaks, a Turkic ethnoconfessional group living mainly in the Nagaybak district of the Chelyabinsk Region of Russian South Urals, were genotyped for HLA-A, -B, -DRB1, -DQA1 and -DQB1 loci using PCR-SSP (low-resolution) and HLA-A29 (
Publikováno v:
HLA. 89(4)
HLA-A*24:374 differs from A*24:03:01:01 by 2 exon 3 bases resulting in a substitution of T163E.
Publikováno v:
HLA. 89(4)
Immunogenetic information is provided on 3 novel HLA-B, -C and -DQB1 alleles.
Autor:
A. J. Lemin, C. Darke
Publikováno v:
International Journal of Immunogenetics. 41:480-483
Two hundred and fifty-four normal blood donors, from a largely UK European population, were sequence-based typed for HLA-A, HLA-B, HLA-C, HLA-DRB1, HLA-DQA1 and HLA-DQB1. The fit to Hardy-Weinberg expectations was good for all loci (all P values >0.5
Publikováno v:
International Journal of Immunogenetics. 41:277-280
Summary Hypersensitivity reactions to the drug abacavir are strongly associated with possession of HLA-B*57:01. Hence, patients with HIV/AIDS who may be prescribed abacavir should be tested for this HLA allele and the drug withheld from those that po